B-cell lymphomas with concurrent MYC, BCL2, BCL6, and CCND1 rearrangements appear to be a rare occurrence; however, current standard approaches to DLBCL/HGBL classification do not require routine testing for CCND1 rearrangement. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.